Karina Jahnz-Różyk
Zdrowie Publiczne i Zarządzanie, Tom 11, Numer 1, 2013, s. 69 - 78
https://doi.org/10.4467/20842627OZ.14.007.1617Psoriasis biological treatment in Poland
Biologics are an important, but expensive treatment option in certain inflammatory diseases. Psoriasis is chronic disease that is a major public health problem in all countries. The paper shows the practical applicability of biological agents in this disease therapy. Many aspects of the clinical, cost and availability of biological treatment of psoriasis in Poland were discussed.
Karina Jahnz-Różyk
Zdrowie Publiczne i Zarządzanie, Tom 11, Numer 1, 2013, s. 1 - 15
https://doi.org/10.4467/20842627OZ.14.001.1539The principles of pharmaceutical reimbursement in the Polish health care system - overview of changes after implementation of the pharmaceutical reimbursement law and analysis of their impact on the physician-patient relationships
A very important new law (the Reimbursement Law) has been implemented in Poland on turn of years 2011 and 2012 and it has deeply changed the national pharmaceutical pricing and reimbursement policy. The aim of this paper is to characterize the current status of affairs in this area and also to analyze the influence of changes on relationship between physicians and patients. The implementation of the Reimbursement Law has had a multifaceted impact on the Polish health care system and it has interfered relationships among its stakeholders. Several amendments to the new law are being expected in the forthcoming years, so all relevant experiences of the various stakeholders should be taken into due consideration during further pharmaceutical policy reforms. Appropriate preparations should be made beforehand, involving not only the state regulator and the public payer.